Cambridge Investment Research Advisors
ONEM

Cambridge Investment Research Advisors’s 1Life Healthcare ONEM Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,050
Closed -$236K – 3188
2021
Q1 		$236K Sell
6,050
-139
-2% -$6.53K ﹤0.01% 2473
2020
Q4 		$270K Buy
+6,189
New +$211K ﹤0.01% 2235

Other funds holding ONEM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Cambridge Investment Research Advisors's ONEM Position: Q2 2021 in Review

Cambridge Investment Research Advisors sold out of 1Life Healthcare (ONEM) in Q2 2021, closing a stake of 6,050 shares — an estimated $236K sold.

Cambridge Investment Research Advisors first reported a position in ONEM in Q4 2020 and held it in 2 quarters. The position peaked at $270K in Q4 2020. 220 funds tracked by Wall St. Rank hold ONEM as of Q2 2021.

  • Cambridge Investment Research Advisors reported no remaining 1Life Healthcare position as of Q2 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 6,050 1Life Healthcare shares in Q2 2021, an estimated $236K.
  • Cambridge Investment Research Advisors first reported a position in 1Life Healthcare in Q4 2020 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's 1Life Healthcare position peaked at $270K in Q4 2020.
  • 220 funds tracked by Wall St. Rank held 1Life Healthcare as of Q2 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.